The role of substance P in epilepsy and seizure disorders
- PMID: 29100462
- PMCID: PMC5652851
- DOI: 10.18632/oncotarget.20606
The role of substance P in epilepsy and seizure disorders
Erratum in
-
Correction: The role of substance P in epilepsy and seizure disorders.Oncotarget. 2019 May 28;10(37):3576. doi: 10.18632/oncotarget.26991. eCollection 2019 May 28. Oncotarget. 2019. PMID: 31191827 Free PMC article.
Abstract
A range of evidence implicates the neuropeptide substance P (SP), a member of the tachykinin family, in emotional behavior, anxiety, pain, and inflammation. Recently, SP has been implicated in susceptibility to seizures, for which a potential proconvulsant role was indicated. Indeed, antagonists of a specific SP receptor, neurokinin-1 receptor, were found to attenuate kainic acid (KA)-induced seizure activity. However, detailed mechanisms of SP regulation in epilepsy remain obscure. In this review, we summarize the present literature to expound the role of SP in epilepsy, and provide hypotheses for potential mechanisms.
Keywords: epilepsy; inflammation; neuron; substance P.
Conflict of interest statement
CONFLICTS OF INTEREST The authors confirm that this article content has no conflicts of interest.
References
-
- Li B, Tang F, Wang L, Liu L, Zhao J, Zhou Y, Wang Y, Song Y, Li Y, Cui R. Anticonvulsant effects of Fuzi total alkaloid on pentylenetetrazole-induced seizure in mice. J Pharmacol Sci. 2013;123:195–8. - PubMed
-
- Ge T, Yang W, Fan J, Li B. Preclinical evidence of ghrelin as a therapeutic target in epilepsy. Oncotarget. 2017;8:59929–39. https://doi.org/10.18632/oncotarget.18349. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
